Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ashok Kumar Jangid, Hina Agraval, Nitin Gupta, Poonam Jain, Umesh C. S. Yadav, Deep Pooja & Hitesh Kulhari. (2020) Amorphous nano morin outperforms native molecule in anticancer activity and oral bioavailability. Drug Development and Industrial Pharmacy 46:7, pages 1123-1132.
Read now
Read now
Abhijeet D. Kulkarni & Veena S. Belgamwar. (2019) Influence of novel carrier Soluplus® on aqueous stability, oral bioavailability, and anticancer activity of Morin hydrate. Drying Technology 37:9, pages 1143-1161.
Read now
Read now
Yurie Mori, Shinya Kato, Yutaka Fujisawa, Shiho Ohnishi, Yusuke Hiraku, Shosuke Kawanishi, Mariko Murata & Shinji Oikawa. (2019) Mechanisms of DNA damage induced by morin, an inhibitor of amyloid β-peptide aggregation. Free Radical Research 53:1, pages 115-123.
Read now
Read now
Articles from other publishers (19)
Federica De Gaetano, Consuelo Celesti, Giuseppe Paladini, Valentina Venuti, Maria Chiara Cristiano, Donatella Paolino, Daniela Iannazzo, Vincenza Strano, Anna M. Gueli, Silvana Tommasini, Cinzia Anna Ventura & Rosanna Stancanelli. (2023) Solid Lipid Nanoparticles Containing Morin: Preparation, Characterization, and Ex Vivo Permeation Studies. Pharmaceutics 15:6, pages 1605.
Crossref
Crossref
Lovekesh Singh & Shamsher Singh. (2023) Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ (1−42) and NF-kB expression in experimental model of rats. Neuroscience Letters 799, pages 137090.
Crossref
Crossref
Li Du, Lin Chen, Fangfang Liu, Wenya Wang & Hongyun Huang. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors
255
297
.
Ahmed Mohsen Elsaid Hamdan, Fatimah Hussain J. Alharthi, Ahmed Hadi Alanazi, Soad Z. El-Emam, Sameh S. Zaghlool, Kamel Metwally, Sana Abdulaziz Albalawi, Yahia S. Abdu, Reda El-Sayed Mansour, Hoda A. Salem, Zakaria Y. Abd Elmageed & Karema Abu-Elfotuh. (2022) Neuroprotective Effects of Phytochemicals against Aluminum Chloride-Induced Alzheimer’s Disease through ApoE4/LRP1, Wnt3/β-Catenin/GSK3β, and TLR4/NLRP3 Pathways with Physical and Mental Activities in a Rat Model. Pharmaceuticals 15:8, pages 1008.
Crossref
Crossref
Pankaj V. Dangre, Shital B. Shinde, Sanjay J. Surana, Pankaj G. Jain & Shailesh S. Chalikwar. (2022) Development and exploration on flowability of solid self-nanoemulsifying drug delivery system of morin hydrate. Advanced Powder Technology 33:8, pages 103716.
Crossref
Crossref
Wantida Chaiyana, Suwannee Sriyab & Siriporn Okonogi. (2022) Enhancement of Cholinesterase Inhibition of Alpinia galanga (L.) Willd. Essential Oil by Microemulsions. Molecules 27:10, pages 3275.
Crossref
Crossref
Mohamed Y. Zakaria, Paris E. Georghiou, Joseph H. Banoub & Botros Y. Beshay. (2022) Inclusion of a Phytomedicinal Flavonoid in Biocompatible Surface-Modified Chylomicron Mimic Nanovesicles with Improved Oral Bioavailability and Virucidal Activity: Molecular Modeling and Pharmacodynamic Studies. Pharmaceutics 14:5, pages 905.
Crossref
Crossref
Rajwinder Kaur, Ankita Sood, Damanpreet Kaur Lang, Saurabh Bhatia, Ahmed Al-Harrasi, Lotfi Aleya & Tapan Behl. (2022) Potential of flavonoids as anti-Alzheimer’s agents: bench to bedside. Environmental Science and Pollution Research 29:18, pages 26063-26077.
Crossref
Crossref
Flavia Laffleur & Bettina Bauer. (2021) Progress in nasal drug delivery systems. International Journal of Pharmaceutics 607, pages 120994.
Crossref
Crossref
Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri & Bozena Michniak-Kohn. (2021) Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 13:2, pages 201.
Crossref
Crossref
Elena Alberdi, Asier Ruiz, Maria Victoria Sánchez-Gómez, Estibaliz Capetillo-Zarate & Calos Matute. 2021. Mitochondrial Physiology and Vegetal Molecules. Mitochondrial Physiology and Vegetal Molecules
317
337
.
Gen Li, Guizhen Wang, Meng Li, Li Li, Hongtao Liu, Meiyang Sun & Zhongmei Wen. (2020) Morin inhibits Listeria monocytogenes virulence in vivo and in vitro by targeting listeriolysin O and inflammation. BMC Microbiology 20:1.
Crossref
Crossref
Benneth Ben-Azu, Osagie Emokpae, Abayomi Mayowa Ajayi, Thiophilus Aghogho Jarikre, Valiant Orhode, Adegbuyi Oladele Aderibigbe, Solomon Umukoro & Ezekiel O. Iwalewa. (2020) Repeated psychosocial stress causes glutamic acid decarboxylase isoform-67, oxidative-Nox-2 changes and neuroinflammation in mice: Prevention by treatment with a neuroactive flavonoid, morin. Brain Research 1744, pages 146917.
Crossref
Crossref
Hatasu Kobayashi, Mariko Murata, Shosuke Kawanishi & Shinji Oikawa. (2020) Polyphenols with Anti-Amyloid β Aggregation Show Potential Risk of Toxicity Via Pro-Oxidant Properties. International Journal of Molecular Sciences 21:10, pages 3561.
Crossref
Crossref
Joana Bicker, Ana Fortuna, Gilberto Alves & Amílcar Falcão. (2020) Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders. Current Pharmaceutical Design 26:5, pages 594-619.
Crossref
Crossref
Ioanna Theochari, Aristotelis Xenakis & Vassiliki Papadimitriou. 2020. Smart Nanocontainers. Smart Nanocontainers
315
341
.
Jae Young Kwon, Min-Tae Jeon, Un Ju Jung, Dong Woon Kim, Gyeong Joon Moon & Sang Ryong Kim. (2019) Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy. Advances in Nutrition 10:5, pages 778-790.
Crossref
Crossref
Neeraj Mishra, Sawarni Sharma, Rahul Deshmukh, Anoop Kumar & Ruchika Sharma. (2019) Development and Characterization of Nasal Delivery of Selegiline Hydrochloride Loaded Nanolipid Carriers for the Management of Parkinson’s Disease. Central Nervous System Agents in Medicinal Chemistry 19:1, pages 46-56.
Crossref
Crossref
Benneth Ben-Azu, Adegbuyi Oladele Aderibigbe, Aya-Ebi Okubo Eneni, Abayomi Mayowa Ajayi, Solomon Umukoro & Ezekiel O. Iwalewa. (2018) Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms. Neurochemical Research 43:9, pages 1745-1755.
Crossref
Crossref